ID: ALA4556355

Max Phase: Preclinical

Molecular Formula: C21H41N3O2

Molecular Weight: 367.58

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCN(CCC(=O)NC)CCC(=O)NC1CCCCC1

Standard InChI:  InChI=1S/C21H41N3O2/c1-3-4-5-6-7-11-16-24(17-14-20(25)22-2)18-15-21(26)23-19-12-9-8-10-13-19/h19H,3-18H2,1-2H3,(H,22,25)(H,23,26)

Standard InChI Key:  FBGZIBJTYWZXQV-UHFFFAOYSA-N

Associated Targets(Human)

Isoprenylcysteine carboxyl methyltransferase 596 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 367.58Molecular Weight (Monoisotopic): 367.3199AlogP: 3.62#Rotatable Bonds: 14
Polar Surface Area: 61.44Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.81CX LogP: 3.36CX LogD: 0.98
Aromatic Rings: 0Heavy Atoms: 26QED Weighted: 0.46Np Likeness Score: -0.91

References

1. Marín-Ramos NI, Balabasquer M, Ortega-Nogales FJ, Torrecillas IR, Gil-Ordóñez A, Marcos-Ramiro B, Aguilar-Garrido P, Cushman I, Romero A, Medrano FJ, Gajate C, Mollinedo F, Philips MR, Campillo M, Gallardo M, Martín-Fontecha M, López-Rodríguez ML, Ortega-Gutiérrez S..  (2019)  A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia.,  62  (13): [PMID:31181882] [10.1021/acs.jmedchem.9b00145]

Source